Comparison of Activation versus Induction of Unresponsiveness of Virus-Specific CD4+ and CD8+ T Cells upon Acute versus Persistent Viral Infection  by Oxenius, Annette et al.
Immunity, Vol. 9, 449±457, October, 1998, Copyright 1998 by Cell Press
Comparison of Activation versus Induction
of Unresponsiveness of Virus-Specific CD41 and CD81
T Cells upon Acute versus Persistent Viral Infection
et al., 1993a, 1993b; Oxenius et al., 1998b). Similar find-
ings have been suggested for chronic HBV (Rehermann
et al., 1995, 1996 ) and HIV infection (Carmichael et al.,
1993; Zinkernagel and Hengartner, 1994). In contrast to
CD81 T cells, much less is known about the functional
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Schmelzbergstr. 12 status of virus-specific CD41 T cells during establish-
ment of a persistent virus infection. In patients persis-8091 ZuÈ rich
Switzerland tently infected with HBV, a strongly reduced HBV-spe-
cific proliferative response as compared to acutely
infected patients was reported (Ferrari et al., 1990), and
in HIV-infected individuals it is virtually impossible toSummary
assess HIV-specific CD41 T cell responses (Shearer and
Clerici, 1991). This could at least partly be explained byThe functional status of CD41 T cells during establish-
the infection of activated CD41 T cells, which impairsment of persistent infection with the noncytopathic
their function, reduces their life-span, and renders themlymphocytic choriomeningitis virus was assessed and
susceptible to HIV-specific CTLs in vivo (Ho, 1995; Perel-compared to that of cytotoxic CD81 T cells. Functional-
son et al., 1996). Interestingly, a recent report demon-ity of virus-specific CD41 T cells was measured by
strated that HIV-specific CD41 T cell responsivenessproliferative responses, cytokine secretion, cognate
could be observed in asymptomatic patients with veryhelp, and IFNg-mediated protection against challenge
low/absent viremia (Rosenberg et al., 1997).infection with recombinant vaccinia virus. Functional
In this study we examined the functional status ofCD41 T cells were induced early after infection and
LCMV-specific CD41 T cells after infection with the non-remained measurable up to 6 weeks but then were
cytopathic LCMV leading to persistent viral infection.rendered unresponsive. In contrast, CD81 T cells were
Our experiments in normal mice and in adoptive transferfunctionally inactivated within 10±15 days. Impor-
experiments using LCMV-derived glycoprotein (LCMV-tantly, functional inactivation of virus-specific CD41 T
GP)-specific TCR transgenic (tg) CD41 or CD81 T cellscells during persistent viral infection seemed to be
demonstrated that CD81 T cells were rendered unre-critical for the survival of the host.
sponsive in persistently infected recipients within 10±15
daysÐconsiderably faster than CD41 T cells, whichIntroduction
were rendered unresponsive within 6±7 weeks.
Viral infections often follow an acute time-limited course
of replication and spread that is resolved by cellular Results
and/or humoral immune effector functions. However,
under certain circumstances, certain viruses can cause Assessment of In Vivo T Help in Acute
persistent infection. The mechanisms by which viruses or Persistently Infected Mice
persist over long time periods in the host differ from In order to compare functional activity of LCMV-specific
one virus to another. Dependent upon the viral antigenic CD41 T cells during the time course of low-dose (virus
load accessible to the immune system, this might differ- being cleared within 14 days) or high-dose (leading to
ently affect virus-specific immune responsiveness. Non- persistent infection) LCMV-DOCILE infection, in vivo T
cytopathic viruses such as the lymphocytic choriomen- help was assessed in two different experimental setups.
ingitis virus (LCMV), hepatitis B virus, or HIV can cause First, LCMV-NP-specific ELISA-binding IgG antibody re-
persistent infections with overwhelming antigenic viral sponses were determined 50 or 100 days after infection
load (Moskophidis et al., 1993b; Chisari, 1995; Ho, 1995). of C57BL/6 mice (Figure 1). Since the initiation of IgG
Similarly, lactate dehydrogenase activating virus (LDV), responses, but not the persistence of memory B cells
although a highly cytopathic virus, can induce persistent and memory IgG titers, is strictly dependent on func-
infection with high antigenic load due to its very re- tional T help (Leist et al., 1987; Ahmed et al., 1988; Vieira
stricted host cell tropism (Plagemann and Moennig, and Rajewsky, 1990), the pronounced IgG responses
1992; van den Broek et al., 1997). In contrast, other indicated that LCMV-specific T help was functionally
viruses such as herpes simplex virus or cytomegalovirus induced after low- and high-dose infection. Second, in
have the ability to persist in a latent form that results in order to directly assess functional LCMV-specific T help
a minimal antigenic load virtually inaccessible to the in vivo at given time points of infection, a challenge
immune system (Stevens and Cook, 1971; Jordan, 1978). immunization of infected mice was performed using pu-
In the case of persistent overwhelming LCMV infec- rified, inactivated, deaggregated LCMV-DOCILE that
tion, it has been shown that LCMV-specific CD81 T cells had been covalently modified with dinitrophenol moie-
are exhausted and thus functionally rendered unrespon- ties (DOC-DNP). Intravenous immunization with a lim-
sive and are eventually physically deleted (Moskophidis iting amount of DOC-DNP induced a DNP-specific IgG
response 7 days after challenge in low-dose LCMV
memory mice but not in naive control mice, indicating* To whom correspondence should be addressed (e-mail: aoxenius@
pathol.unizh.ch). that functional LCMV-specific T help was required to
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Figure 1. LCMV-NP-Specific IgG Response in LCMV-DOCILE-
Infected Mice 50 or 100 Days after Infection
C57BL/6 mice were infected with 1 3 102 PFU (square) or 1 3 106
PFU (circle) LCMV-DOCILE, and 50 or 100 days later, LCMV-NP-
specific IgG antibodies were determined by ELISA in 30-fold predi-
luted sera. Triangles represent sera from naive C57BL/6 mice. Each
line represents one individual mouse. One of three comparable ex-
periments is shown.
Figure 2. DNP-Specific IgG Antibody Responses
(A) C57BL/6 mice were infected with 1 3 102 PFU LCMV-DOCILEconfer help to DNP-specific B cells (Freer et al., 1995;
(circle) or were left untreated (square) and were challenged intrave-
Oxenius et al., 1998a). Thus, mice that had been infected nously at the indicated time points with 5 mg DNP-DOCILE.
with low or high doses of LCMV were challenged at (B) C57BL/6 mice were infected with a 1 3 106 PFU LCMV-DOCILE
(circle) or were left untreated (square) and were challenged intrave-different time points (days 14, 25, 45, 55, 70, 90, and
nously at the indicated time points with 5 mg DNP-DOCILE. Seven150) with DOC-DNP. DNP-specific IgG titers were deter-
days after the challenge immunization, DNP-specific IgG titers weremined 7 days later (Figure 2). Interestingly, whereas
determined in 30-fold prediluted sera by ELISA. Each line representsLCMV-specific T help was functional at all time points
one individual mouse. One of three comparable experiments is
up to 200 days (data not shown) after low-dose infection shown.
(Figure 2A), LCMV-specific T help was only functional
within the first 6±7 weeks after infection with high-dose
LCMV (Figure 2B). These results suggest that LCMV- also appeared in peripheral blood. Whereas the percent-
specific T help was rendered unresponsive during over- age of TCR tg CD41 T cells remained constant in the
whelming persistent viral infection but with significantly spleen over long periods of time (day 14±55; about 10%±
slower kinetics compared to virus-specific CD81 T cells, 15% of total CD41 T cells), the percentage of TCR tg
which exhaust within the first 10±15 days after high- CD81 T cells dropped after 35 days upon adoptive trans-
dose LCMV infection (Moskophidis et al., 1993b). fer to barely detectable levels and was undetectable at
55 days after transfer. These results differ from previous
reports where it was documented that CD81 TCR tg TAdoptive Transfer of LCMV-GP-Specific CD41
or CD81 TCR Tg T Cells into Persistently cells were clonally deleted 15 days after transfer into
LCMV carrier mice (Moskophidis et al., 1993a). In thoseInfected Recipient Mice
In order to correlate and compare physical and func- experiments, however, CD81 TCR tg T cells originated
from a TCR tg mouse line (327), which was not from puretional behavior of LCMV-GP-specific CD81 T cells and
CD41 T cells, LCMV-specific TCR tg CD81 T cells (318) C57BL/6 background. In contrast, the TCR tg mouse line
318 used in this report has been backcrossed to C57BL/(Pircher et al., 1989) or LCMV-specific TCR tg CD41 T
cells (SMARTA) (Oxenius et al., 1998a) were transferred 6 mice for at least eight generations. Therefore, rejec-
tion due to partial minor histoincompatibility antigensinto recipients that had been persistently infected with
LCMV-DOCILE. Clonal expansion and disappearence of could explain these discrepancies, which have been
addressed and explained in a recent correction (Oxeniustransferred cells in the blood and spleen of recipients
were monitored by FACS analysis using TCR Va- and et al., 1998b).
In all transfer experiments, virus titers remained con-Vb-specific monoclonal antibodies (Figure 3A). Both
transfer of SMARTA tg T cells and 318 tg T cells into stant and no CD41 T cell escape mutants could be de-
tected (Table 1). For the potential selection of CD41 T cellpersistently infected recipients resulted in a drastic
clonal expansion (Figure 3A). The distribution of TCR tg epitope (P13-specific) T cell escape mutants, subcloned
LCMV isolates were functionally analyzed: LCMV wasT cells in peripheral blood compared to spleen showed
that CD41 T cells were initially present both in blood isolated from the blood of LCMV carrier mice 60 or 100
days after transfer of SMARTA tg T cells. Subsequently,and spleen. Fourteen days after transfer, the CD41 TCR
tg T cells were predominantly present in the spleen. The plaque-purified LCMV clones were tested for their ability
to activate P13-specific naive SMARTA tg T cells in vitro.CD81 T cells were initially predominantly found in the
spleen, and only 14 days after adoptive transfer they In addition, these virus clones were tested for MHC class
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Figure 3. LCMV-Specific Responsiveness of
CD41 or CD81 TCR Tg T Cells after Adoptive
Transfer into Persistently Infected Recipient
Mice
(A) Clonal expansion of adoptively transferred
CD41 or CD81 TCR tg T cells. Spleen cells
(2 3 106) from SMARTA tg mice (circle, left
panels) or 1 3 106 spleen cells from 318 tg
mice (circle, right panels) were transferred
into persistently infected mice. At the indi-
cated time points, percentages of TCR tg T
cells were assessed in the blood and in the
spleen by FACS analysis using appropriate
TCR Va- and Vb-specific monoclonal anti-
bodies. Triangles represent percentages of
TCR tg T cells in naive control mice that had
been transfused with the same numbers of
TCR tg T cells. Each symbol represents one
individual mouse. One of three comparable
experiments is shown.
(B) LCMV-specific cytotoxic T cell activity.
Spleen cells (1 3 106) from naive 318 tg mice
were transferred into persistently infected
C57BL/6 mice, and secondary in vitro cyto-
toxic activity was determined at the indicated
time points after infection by 51Cr release
assay with gp33-loaded (circle) or unloaded
(square) EL4 target cells. Each line represents
one individual mouse. One of three compara-
ble experiments is shown.
(C) LCMV-specific proliferation of purified
CD41 T cells. Spleen cells (2 3 106) from naive
SMARTA tg mice were transferred into persis-
tently infected C57BL/6 mice. At the indi-
cated time points, CD41 T cells were purified
from the spleens. CD41 T cells were restimu-
lated with serial dilutions of the relevant pep-
tide P13 or of the irrelevant peptide P61 in
the presence of irradiated naive C57BL/6 spleen cells. Proliferation was determined by [3H]thymidine incorporation 3 days after restimulation.
Stimulation indices were calculated in relation to proliferation in medium control. Background counts per minute in medium control were
around 3000. One of three equivalent experiments is shown.
(D) LCMV-specific IL-2 secretion. Supernatants from the above described proliferation assays were serially diluted and IL-2 contents were
determined 24 hr after restimulation using the IL-2-sensitive cell line CTLL-2. Circles represent supernatants from P13-restimulated CD41 T
cells and squares represent those from P61-restimulated CD41 T cells. One of three equivalent experiments is shown.
II±associated P13-presentation by measuring activation and 30 days after transfer but was drastically reduced
50 days after transfer (Figure 3C), even though 10% ofof the P13-specific CD41 T cell hybridoma 5A1 (Oxenius
et al., 1995). Both experimental setups revealed identical TCR tg CD41 T cells could constantly be detected in
the spleen between 15 and 50 days after transfer (Figureresults: tg TCR escape mutants were very rare and ap-
parently not positively selected for, since no significant 3A). Antigen-induced IL-2 secretion was measurable up
to 30 days after transfer but had disappeared by 50 daysdifference in the percentage of LCMV clones escaping
recognition by naive SMARTA CD41 T cells could be (Figure 3D). Addition of exogenous recombinant IL-2 did
not restore the proliferative capacity. In addition, cultureobserved in LCMV carrier mice transfused with SMARTA
T cells as compared to nontransfused control carrier of unresponsive CD41 T cells in the absence of antigen
and presence of recombinant IL-2 did not rescue themice (Table 1).
Functional Activity of Adoptively Transferred proliferative response (data not shown). These results
indicate that the kinetics of induction of unrespon-TCR Tg T Cells
CD81 T cells were tested for secondary in vitro cytotoxic siveness differed for CD81 T cells and CD41 T cells with
specificity for the same viral glycoprotein.T cell activity on gp33-pulsed target cells (Moskophidis
et al., 1993a; Oxenius et al., 1998b) (Figure 3B), and CD41 To ascertain that the observed loss of proliferation
and IL-2 secretion was not due to limiting numbers ofT cells were assessed by recall proliferation and IL-2
secretion using the TCR-specific peptide P13 for in vitro TCR tg CD41 T cells in the in vitro assays, naive TCR
tg CD41 T cells were titrated into these cultures. It wasactivation (Oxenius et al., 1998a) (Figures 3C and 3D).
Cytotoxic activity of transferred TCR tg CD81 T cells found that 1 3 104 TCR tg CD41 T cells per culture
well yielded maximal proliferative responses as well ascould be observed 9 and, to a diminished level, 16 days
after transfer but was absent 30 and 50 days after trans- maximal IL-2 secretion (data not shown). In all experi-
ments at least 1 3 104 recovered TCR tg CD41 T cellsfer (Figure 3B). In contrast, specific proliferation of trans-
ferred CD41 TCR tg T cells could be observed 9, 16, 25, were used per culture well. Furthermore, the functional
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at the indicated time points after adoptive transfer ofTable 1. LCMV Subclones Isolated from Carrier Mice Transfused
SMARTA tg T cells into persistently infected recipientswith SMARTA Tg CD41 Cells 60 or 100 Days before Virus
confirmed that the transferred CD41 T cells were func-Isolation
tional up to 35 days after transfer but not at 55 days
Numbers of SMARTA TCR Escape Virus
after transfer (Figure 4A).Clones per Screened Clones
To demonstrate more generally the unresponsiveness
Mouse 1 Mouse 2 Mouse 3 Total of LCMV-specific CD41 T cells in LCMV carrier mice,
transplacentally infected LCMV carrier mice or naiveSMARTA tf into 0/12 1/12 0/12 1/36
carrier (d60) C57BL/6 mice (with or without CD4 T cell depletion) were
SMARTA tf into 0/12 0/11 0/11 0/34 challenged intravenously with 20 mg of deaggregated,
carrier (d100) inactivated, purified LCMV-DNP. Seven days after chal-
No tf into 1/12 0/12 1/12 2/36
lenge, DNP-specific IgG titers were determined in thecarrier (d60)
serum (Figure 4B). Neither CD4-depleted nor untreated
LCMV was isolated from the blood of nine different LCMV carrier LCMV carrier mice nor naive C57BL/6 control mice
mice and plaque purified. LCMV carrier mice had either been trans- mounted a measurable DNP-specific IgG response. In
fused with SMARTA tg CD41 T cells 60 or 100 days previously or had
contrast, low-dose LCMV memory mice mounted a sig-been left untreated. From each mouse, 12 subclones were tested for
nificant DNP-specific IgG response. This response wastheir capacity to activate naive SMARTA tg CD41 T cells by means
abrogated by depletetion of CD41 T cells. These resultsof in vitro proliferation or induction of IL-2 release. In addition, virus
subclones were tested for MHC class II±associated presentation of demonstrated that preexistent antibodies to LCMV did
the LCMV-GP-derived epitope P13 (aa 61±80) by activation of the not interfere with detection of LCMV-specific T help.
P13-specific T cell hybridoma 5A1. All three assay methods revealed Thus, no LCMV-specific T help could be measured in
the same results. Numbers of SMARTA TCR escape clones per transplacentally infected LCMV carrier mice, at least
total number of tested LCMV clones are shown separately for each
with this experimental setup.mouse.
Ability of TCR Tg CD41 T Cells to Express Surface
Activation Markers
In addition to the functional assessment of CD41 T cells
activity of SMARTA tg T cells was significant within the upon transfer into virus carrier recipients, we analyzed
first 35 days but declined by day 50 after transfer to whether the tg CD41 T cells were still able to express
approximately background levels, while the percentage surface activation markers after peptide stimulation in
of SMARTA tg T cells in the spleen constantly remained vitro. Thus, CD41 TCR tg T cells recovered either 16 or
at 10% (Figure 3). 50 days after transfer were stimulated in vitro for 24 hr
In addition, functional T help was assessed directly with the relevant peptide P13, and surface expression
in vivo by immunization with a molecule consisting of a of CD69 and IL-2R was analyzed. Whereas the TCR tg
BSA core protein to which the P13 was covalently cou- CD41 T cells were still able to upregulate CD69 and IL-
pled, which was in addition covalently modified with 2R 16 days after transfer, they no longer upregulated
DNP moieties (BSA-P13-DNP) (Oxenius et al., 1998a). IL-2R 50 days after transfer (data not shown).
Using deaggregated BSA-P13-DNP for intravenous im- Protective Immunity against Challenge Infection
munization allowed the assesssment of P13-specific with Recombinant Vaccinia Virus
primed functional T help in vivo by measuring DNP- Expressing LCMV-GP
specific IgG responses 7 days after challenge (Oxenius A further means of analyzing the functional status of
transferred LCMV-GP-specific TCR tg CD41 or CD81 Tet al., 1998a). BSA-P13-DNP immunizations performed
Figure 4. DNP-Specific IgG Antibody Re-
sponses
(A) Spleen cells (2 3 106) from naive SMARTA
tg mice were transferred into persistently in-
fected C57BL/6 mice. At the indicated time
points, transfused (circle) or naive control
mice (square) were challenged intravenously
with 10 mg deaggregated DNP-P13-BSA.
Seven days after immunization, DNP-specific
IgG titers were determined in 30-fold predi-
luted sera by ELISA. The mean of five mice
per experimental group is shown.
(B) Transplacentally infected LCMV carrier
mice or naive C57BL/6 control mice that ei-
ther had been depleted of CD41 T cells in
vivo or left untreated were immunized intrave-
nously with 20 mg of DNP-modified, deag-
gregated, inactivated, purified LCMV. In addi-
tion, day 40 infected LCMV memory C57BL/6
mice (with or without depletion of CD41 T
cells) were challenged with LCMV-DNP. DNP-
specific IgG titers were determined 7 days
later in 30-fold prediluted serum. The mean
of five mice per experimental group is shown.
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transfer with LCMV, and expansion of TCR tg CD41 T
cells was monitored in the blood and in the spleen.
LCMV infection did not induce measurable clonal expan-
sion of SMARTA tg T cells that had been exposed to
high doses of viral antigen for 55 days (not shown). In
contrast, transferred naive SMARTA tg T cells showed
pronounced clonal expansion at both time points after
virus challenge (data not shown).
These data suggest that LCMV-specific CD41 T cells,
rendered unresponsive by exposure for 55 days to an
overwhelming antigen dose in persistently infected
mice, could not revert to a proliferative functional status
upon adoptive transfer into a largely antigen-free envi-
ronment. However, it has to be noted that a few virus
particles had been cotransferred with the purified CD41
T cells and, despite the treatment with hyperimmune
serum, resulted in acute LCMV infection. Since a small
fraction of the CD41 T cells has been shown to be in-Figure 5. T Cell±Dependent, Cytokine-Mediated Protection against
Challenge Infection with Recombinant Vaccinia Virus fected in LCMV carrier mice (Borrow et al., 1991), it
Persistently infected mice were transfused with 2 3 106 spleen cells is virtually impossible to circumvent transfer of a few
from SMARTA tg mice (left panel) or with 1 3 106 spleen cells from infected cells. However, the virus load in these mice
318 tg mice (right panel). At the indicated time points, recipient was certainly much below the one in persistently in-
mice were challenged intraperitoneally with 2 3 106 PFU Vacc-G2. fected mice and was time-limited due to the neutralizing
Vaccinia titers in ovaries were determined 5 days after challenge
antibodies and the recipients' efficient CD81 T cell re-infection. Each symbol represents an individual mouse. One of two
sponse. These results differ from other reports whereexperiments is shown.
unresponsive CD41 T cells could be rescued in terms of
their functional activity within a few days upon adoptive
cells was the assessment of protection against a chal- transfer into truly antigen-free recipients (Bachmann et
lenge infection with recombinant vaccinia virus express- al., 1994).
ing the LCMV-GP (VV-G2). Protection against VV-G2 is
conferred by the release of type 1 cytokines (IFNg and
TNFa) by LCMV-GP-specific CD41 or CD81 T cells Inefficient/Absent Induction of Unresponsiveness
in LCMV-Specific CD41 T Cells Leads to Fatal(Binder and KuÈ ndig, 1991; KuÈ ndig et al., 1993; Oxenius
et al., 1998a). Thus, persistently infected recipient mice Outcome of Persistent LCMV Infection
Induction of unresponsiveness of CD41 T cells duringthat had received TCR tg CD41 or CD81 T cells were
challenged with VV-G2 on day 9, 27, 40, or 65 after persistent and overwhelming viral infection might be
of critical importance for survival, since pathologicalcell transfer, and 5 days later vaccinia virus titers were
determined in the ovaries (Figure 5). Recipients of TCR effects of unimpaired virus-specific CD41 T cell activi-
ties have been described (Zajak et al., 1996). Indeed, iftg CD41 T cells were protected against challenge infec-
tion at 9, 27, and 40 days after transfer but no longer the numbers of virus-specific CD41 T cells are drastically
elevated, e.g., in LCMV-specific TCR tg mice (Oxeniusthan day 65 after transfer. In contrast, recipients of TCR
tg CD81 T cells were only protected against a challenge et al., 1998a), infection with high doses of LCMV is lethal,
whereas it causes a tolerated persistent infection in nor-infection at day 9 but no longer at 27, 40, and 65 days
after transfer. These results corroborate the previous mal mice (Table 2.1). In line with this, adoptive transfer
of purified CD41 TCR tg T cells into naive C57BL/6 nu/findings that virus-specific CD41 T cells are functional
in persistently infected mice for considerably longer time nu recipients followed by infection with LCMV (which
cannot be controlled in the absence of CD81 T cells) ledperiods than virus-specific CD81 T cells.
to wasting disease and eventually death in the recipient
nude animals (Table 2.2). Thus, LCMV-specific CD41Proliferative Activity of Unresponsive CD41 TCR
Tg T Cells Cannot Be Restored by Transfer T cells can cause lethality during uncontrolled LCMV
infection. Successful inactivation of virus-specific CD41into Naive, Antigen-Free Recipients
To address the question of whether unresponsive CD41 T cells depends upon frequencies of specific CD41 T
cells (Kearney et al., 1994; FoÈ rster et al., 1995; LanoueTCR tg T cells are able to regain their proliferative capac-
ity upon transfer into virus-free recipient mice, SMARTA et al., 1997), with low frequencies being inactivated more
readily than high frequencies.tg T cells, having been exposed to LCMV in a persistently
infected host for 55 days, were purified to 99.8% purity It was of interest to determine whether SMARTA tg T
cells rendered unresponsive 60 days after transfer intoand transferred into naive C57BL/6 mice. The purified
CD41 T cells were incubated with anti-LCMV-specific LCMV carrier mice could still cause lethality upon trans-
fer into C57BL/6 nu/nu recipients (Table 2.3). CD41 Thyperimmune serum (containing LCMV-neutralizing an-
tibodies) before transfer in order to minimize infectious cells were purified from the spleen of LCMV carrier mice
60 days after transfer of SMARTA tg T cells. Purifiedvirus transfer. As a control, equivalent numbers of naive
SMARTA tg cells were transferred into naive recipients. CD41 T cells (1 3 107; containing 1 3 106 TCR tg CD41
T cells) were adoptively transferred into C57BL/6 nu/nuRecipient mice were challenged 1 or 8 days after cell
Immunity
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Table 2.1. Lethal Effects of High-Dose LCMV Infection in LCMV-GP±Specific CD41 TCR Tg Mice (SMARTA)
Lethality (Dead Mice/Total Mice)
No treatment Anti-CD4 Anti-CD8
SMARTA, 106 PFU DOC 10/10 (d30) 0/4 (d30) 4/4 (d30)
B6, 106 PFU DOC 0/20 (d30) 0/4 (d30) 0/4(d30)
SMARTA TCR tg mice were left untreated or were depleted of CD41 or CD81 T cells before infection with high doses of LCMV-DOCILE (106
PFU i.v.). Death of the mice was monitored daily. Results are shown as (dead mice/total number of mice per group) at day 30 after infection.
One of three equivalent experiments is shown.
Table 2.2. Lethal Effects of LCMV Infection in C57BL/6 Nu/Nu Mice Transfused with SMARTA Tg T Cells
Lethality (Dead Mice/Total Mice)
Transfer (Tf) of 1 3 107 Naive No Transfer
SMARTA Tg T Cells
B6 nu/nu LCMV-WE 6/6 (d15) 0/6 (d15)
200 PFU I.V.
CD41 T cells (1 3 107) purified from SMARTA tg mice were transferred into C57BL/6 nu/nu mice, and 3 days later recipients and control
C57BL/6 nu/nu mice were infected with a low dose of LCMV-WE (200 PFU) i.v. Death of the mice was monitored daily. Results are shown as
(dead mice/total number of mice per group) at day 15 after infection. One of three equivalent experiments is shown.
Table 2.3. Lethal Effects of Adoptive Transfer of Naive or Unresponsive SMARTA Tg T Cells into LCMV-Infected C57BL/6 Nu/Nu Mice
Tf of 1 3 106 Naive SMARTA Tf of 1 3 107 CD41T cellsa from Tf of 1 3 107 CD41
Cells 1 1 3 107 CD41 T Cells LCMV carrier mice transfused T cells from
from LCMV Carrier Mice with SMARTA cells (d60) LCMV carrier mice
B6 nu/nu 4/4 (d9) 0/4 (d9) 0/4 (d9)
a CD41 T cells (1 3 107) purified from LCMV carrier mice that had been transfused with SMARTA CD41 T cells 60 days previously were
adoptively transferred into C57BL/6 nu/nu recipients; these purified CD41 T cells contained 10% SMARTA tg T cells.
Death of the mice was monitored daily. Results are shown as (dead mice/total number of mice per group) at day 9 after infection. One of two
equivalent experiments is shown.
recipients. In parallel, 1 3 107 purified CD41 T cells from results in which it was shown that loss of functionality
of transferred TCR tg CD81 T cells coincided with physi-untransfused LCMV carrier mice (as source of ªcontami-
natingº infectious virus [Borrow et al., 1991]) were trans- cal deletion of these transferred TCR tg CD81 T cells
(Moskophidis et al., 1993a). These discrepancies haveferred into C57BL/6 nu/nu recipients with or without
1 3 106 naive SMARTA tg CD41 T cells. Survival of now been explained by the fact that in the former experi-
ments, CD81 TCR tg T cells were obtained from a TCRthe recipient animals was monitored. Recipients that
received naive SMARTA tg T cells succumbed 8 days tg mouse line (327) that was not from a sufficiently pure
C57BL/6 background. Therefore, rejection of transferredafter transfer, whereas recipients that received unre-
sponsive SMARTA tg T cells or CD41 T cells from un- CD81 T cells due to partial minor histoincompatibility
antigen differences could explain these differences (Ox-transfused LCMV carrier mice survived the adoptive
transfer. These findings support the notion that it might enius et al., 1998b).
These findings raised questions about the reasons forbe of critical importance for the survival of the host to
render virus-specific CD41 T cells unresponsive during the kinetic differences in induction of unresponsiveness
of virus-specific CD41 and CD81 T cells. Since, in thepersistent and overwhelming viral infection.
case of the adoptive transfer experiments into persis-
tently infected recipients, both TCR tg CD41 and CD81 TDiscussion
cells were specific for the LCMV-GP, the overall antigen
dose was equivalent for both CD41 and CD81 TCR tgThis study documents a substantial difference in kinet-
ics of induction of unresponsiveness of LCMV-GP-spe- T cells. However, differences in the numbers of MHC±
peptide complexes to be recognized by the TCR tg Tcific CD41 and CD81 T cells in unmanipulated C57BL/6
mice. Corresponding observations were made in adop- cells are most probably of relevance. In a mouse persis-
tently infected with LCMV, viral titers are high in mosttive transfer experiments where LCMV-specific TCR tg T
cells were transferred into persistently infected recipient organs and different cell types are infected. This leads
to MHC class I presentation of virus-derived epitopesmice. CD81 T cells were rendered unresponsive within
10±15 days as opposed to CD41 T cells being function- on many cell types in lymphoid and also in nonlymphoid
tissues that are largely MHC class II negative. Therefore,ally active for up to 5±6 weeks after transfer. CD81 TCR
tg T cells as well as CD41 TCR tg T cells exposed to virus-specific CD81 T cells are constantly confronted
with specific MHC±peptide complexes outside of lym-high doses of viral antigen in LCMV carrier mice clonally
expanded. CD81 TCR tg T cells were physically present phoid tissue that could more quickly cause exhaustion,
possibly by starvation of these CD81 T cells. In contrast,in secondary lymphoid organs up to 30 days after trans-
fer, whereas CD41 TCR tg T cells were detectable for at MHC class II molecules are normally only expressed on
professional APCs, mostly in lymphoid tissues rich inleast 55 days. This is in contrast to previously published
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interleukins and costimulatory signals, i.e., an environ- high for complete inactivation by persistent viral infec-
tion and, moreover, the constant activation of high num-ment which normally favors T cell activation. These geo-
graphical distribution factors as well as perhaps the bers of LCMV-specific CD41 T cells has deleterious con-
sequences for the host. The mechanisms responsibleconcentration of MHC LCMV-GP peptide molecules per
cell might at least partially explain the differences in for the fatal outcome of infection are currently under
investigation. Other studies investigating in vivo induc-induction of unresponsiveness of LCMV-specific CD81
versus CD41 T cells. tion of CD41 T cell unresponsiveness revealed also that
this process depends on the amount of antigen as wellAnother factor that might contribute to this difference
could be that the TCR of CD81 318 tg T cells (Pircher as on the frequency of antigen-specific CD41 T cells
(FoÈ rster et al., 1995; Kearney et al., 1994; Lanoue et al.,et al., 1989) might exhibit a much higher avidity for Db 1
gp33 than the TCR of CD41 SMARTA T cells (Oxenius 1997).
Importantly, CD41 TCR tg T cells rendered unrespon-et al., 1998a) toward I-Ab 1 P13. Although it is impossible
to address this question thoroughly without soluble sive after adoptive transfer into LCMV carrier mice (as
assessed by lack of proliferation, IL-2 secretion, and inMHC±peptide complexes and soluble TCR molecules,
this seemes unlikely. Our experiments showed on a poly- vivo T help) were shown to be unable to cause fatal
disease upon transfer into C57BL/6 nude recipients, asclonal level that normal C57BL/6 mice also show faster
induction of unresponsiveness of CD81 as compared opposed to naive TCR tg CD41 T cells. This supports
the notion that induction of Th cell unresponsivenessto CD41 T cells. In vitro peptide titration experiments
showed that both tg TCRs responded to 1 3 10210 M might be important to secure survival of the host under-
going a persistent virus infection.peptide concentration, suggesting that the avidities
probably do not differ by several orders of magnitude. In conclusion, this study analyzed the fate of LCMV-
specific CD41 T cells upon persistent LCMV infection,The coexistence of functional LCMV-specific TCR tg
CD41 T cells and LCMV for at least 6±7 weeks raised demonstrating that functional responsiveness disap-
peared 6±7 weeks after infection. Comparison of thethe question of whether the presence of LCMV-specific
CD41 T cells selected for virus mutants that escape functional status of defined TCR tg CD41 or CD81 T
cells, both specific for the LCMV-GP, transferred intorecognition by the TCR tg CD41 T cells. Functional anal-
ysis of several LCMV clones isolated from LCMV carrier persistently infected recipient mice showed that the ki-
netics of induction of T cell unresponsiveness are signifi-mice, which had been transfused with TCR tg CD41 T
cells 60 or 100 days previously, showed no selection cantly longer for virus-specific CD41 T cells as com-
pared to virus-specific CD81 T cells.for LCMV T cell epitope escape mutants. Two possibili-
ties may account for this finding. The selective pressure
Experimental Proceduresimposed on the virus by CD41 T cells might not be
strong enough, since it has been shown that even the
Micepresence of drastically elevated precursor frequencies
Inbred C57BL/6 (H-2b) mice were obtained from the breeding colony
of LCMV-specific CD41 T cells does not positively con- of the Institut fuÈ r Labortierkunde, University of ZuÈ rich, ZuÈ rich, Swit-
tribute to viral clearance (Oxenius et al., 1998a). Alterna- zerland. The generation of LCMV-GP-specific CD41 or CD81 TCR
tively, one could argue that the frequencies of trans- tg mice has been described previously (Pircher et al., 1989; Oxenius
et al., 1998a). Mice were bred in an SPF mouse house facility.ferred TCR tg CD41 T cells are not high enough to cause
viral escape. The first possibility seems more likely,
Virusessince high-dose LCMV infection in SMARTA tg mice
The LCMV-DOCILE isolate [a variant isolated from a LCMV-WE
exhibiting drastically elevated LCMV-specific CD41 T (UBC)-carrier mouse] was originally obtained from C. J. Pfau, Troy,
cell frequencies led to a fatal outcome of infection rather New York, and was grown on MDCK cells (ATCC CCL-34) with a
than to tolerated persistent infection, as would have low multiplicity of infection. The LCMV isolate WE was originally
provided by Dr. F. Lehmann-Grube, Hamburg, Germany, and grownbeen expected in the case of selection of virus escape
on L929 cells (ATCC CRL 1) with a low multiplicity of infection.mutants (Table 2.1).
Recombinant vaccinia virus expressing LCMV-GP has been de-In the case of persistent LCMV infection, the high
scribed (Whitton et al., 1988). The recombinant baculovirus express-
amount of antigen constantly present over long time ing the LCMV nucleoprotein and production of recombinant proteins
periods led to the induction of unresponsiveness of have been previously described (Matsuura et al., 1987; Battegay et
LCMV-specific CD41 T cells after 6±7 weeks of virus al., 1993).
exposure. This continuous high antigen load is not
Adoptive Transfers into Persistently Infectedachieved in acutely low-dose infected mice and, thus,
Recipient MiceLCMV-specific CD41 T cells remain functional up to 200
C57BL/6 mice were infected intravenously with 1 3 106 PFU LCMV-days after infection. However, the frequency of LCMV-
DOCILE. Four days later, mice were inoculated intraperitoneally with
specific CD41 T cells also plays an important role for 200 mg cyclophosphamide. Three to four weeks later, viral titers
the induction of CD41 T cell unresponsiveness. In a were analyzed in the blood of all animals and usually 1±10 3 104
normal T cell repertoire or in the case of adoptive transfer PFU/ml blood was detected. For adoptive transfer, 2 3 106 spleen
cells from naive SMARTA tg mice or 1 3 106 spleen cells from naiveexperiments of 3±5 3 105 CD41 TCR tg T cells, unrespon-
318 tg mice were transferred into persistently infected recipients.siveness can be observed 6±7 weeks after persistent
infection or adoptive transfer, respectively. However,
Adoptive Transfers into C57BL/6 Nude Recipientsinfection of SMARTA tg mice with a high dose of LCMV
CD41 T cells were purified from spleen cell suspensions of naive
leads to a fatal outcome of the infection rather than to SMARTA TCR tg mice or from (adoptively transferred) LCMV carrier
induction of CD41 T cell unresponsiveness. Most proba- mice by MACS according to the protocol of the supplier (Miltenyi
Biotec, Germany).bly the number of antigen-specific CD41 T cells is too
Immunity
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Cytofluorometric Analyses 2 3 106 PFU recombinant vaccinia virus expressing the LCMV-glyco-
protein (VV-G2). Vaccinia titers in ovaries were determined 5 daysThe following monoclonal antibodies were used for analysis of TCR
tg peripheral lymphocytes: biotinylated 7G8, specific for Vb8.3 (a later as described previously (Binder and KuÈ ndig, 1991). Titers are
shown as log10 PFU per animal.gift from Dr. I. FoÈ rster [FoÈ rster et al., 1995]); biotinylated anti-Vb8.1/2,
phycoerythrin-conjugated anti-Va2, fluorescein-conjugated anti-
CD8, fluorescein-conjugated anti-CD4, biotinylated anti-CD25, and Acknowledgments
anti-CD69 were purchsed from Pharmingen. Tricolor-conjugated
streptavidin or anti-CD4 were purchased from Caltag Laboratories. We would like to thank Maries van den Broek, Martin F. Bachmann,
and Bea Senn for helpful discussions and suggestions, Alana Al-Flow cytometry was performed on a FACStar Plus flow cytometer
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